Supplementary Figure 9: SMARCA2 (BRM) is repressed in wild-type and mutant SMARCA4 mESCs.
From: Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers
Expression of SMARCA2 compared to other genes in mutant and wild-type mESCs. Little to no SMARCA2 is expressed in mESCs, either in wild-type or mutant cells. Counting of transcripts reveals that SMARCA2 is expressed at less than 1% compared to SMARCA4, hence confounding effects due to SMARCA2 expression can be excluded. Plotted values are mean normalized expression counts (a.u.), error bars are 95% confidence intervals from independent cell-culture replicates (n=2).
